Boston, MA, December 29, 2021 –(PR.com)– Viron Therapeutics Holdings, Inc., a Boston biotech company, is pleased to announce the appointment of Jodie Fisher as its Executive Vice President and Chief Financial Officer (CFO). Fisher will lead the Company’s finance organization and drive investor relations.

Fisher’s entry into Viron’s management team comes at a crucial time as the Company moves forward through the regulatory approval process and leverages its relationships with strategic partners and interested customers to rapidly build its sales. She brings extensive experience in leading companies through the early stages of development and rapid growth. As CFO, Fisher previously led her teams to take a biotech through an IPO, develop health tech solutions for IBM’s Watson IoT, and deliver a financial transformation of a Fortune 50 Insurance giant as Controller.

Gil Marmol, Viron Chief Executive, commented:
“We are…